These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 26992417

  • 1. Transformative therapy in hypophosphatasia.
    Bishop N, Munns CF, Ozono K.
    Arch Dis Child; 2016 Jun; 101(6):514-515. PubMed ID: 26992417
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Enzyme-replacement therapy in life-threatening hypophosphatasia.
    Whyte MP, Greenberg CR, Salman NJ, Bober MB, McAlister WH, Wenkert D, Van Sickle BJ, Simmons JH, Edgar TS, Bauer ML, Hamdan MA, Bishop N, Lutz RE, McGinn M, Craig S, Moore JN, Taylor JW, Cleveland RH, Cranley WR, Lim R, Thacher TD, Mayhew JE, Downs M, Millán JL, Skrinar AM, Crine P, Landy H.
    N Engl J Med; 2012 Mar 08; 366(10):904-13. PubMed ID: 22397652
    [Abstract] [Full Text] [Related]

  • 5. Asfotase Alfa in Perinatal/Infantile-Onset and Juvenile-Onset Hypophosphatasia: A Guide to Its Use in the USA.
    Scott LJ.
    BioDrugs; 2016 Feb 08; 30(1):41-8. PubMed ID: 26832358
    [Abstract] [Full Text] [Related]

  • 6. Hypophosphatasia: From Diagnosis to Treatment.
    Simon S, Resch H, Klaushofer K, Roschger P, Zwerina J, Kocijan R.
    Curr Rheumatol Rep; 2018 Sep 10; 20(11):69. PubMed ID: 30203264
    [Abstract] [Full Text] [Related]

  • 7. Enzyme Replacement Therapy in Hypophosphatasia.
    Uçaktürk SA, Elmaogullari S, Ünal S, Gönülal D, Mengen E.
    J Coll Physicians Surg Pak; 2018 Sep 10; 28(9):S198-S200. PubMed ID: 30173697
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Reappearance of hypomineralized bone after discontinuation of asfotase alfa treatment for severe childhood hypophosphatasia.
    Bowden SA, Adler BH.
    Osteoporos Int; 2018 Sep 10; 29(9):2155-2156. PubMed ID: 29967930
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Hypophosphatasia: Canadian update on diagnosis and management.
    Khan AA, Josse R, Kannu P, Villeneuve J, Paul T, Van Uum S, Greenberg CR.
    Osteoporos Int; 2019 Sep 10; 30(9):1713-1722. PubMed ID: 30915507
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Efficacy and Safety of Asfotase Alfa in Infants and Young Children With Hypophosphatasia: A Phase 2 Open-Label Study.
    Hofmann CE, Harmatz P, Vockley J, Högler W, Nakayama H, Bishop N, Martos-Moreno GÁ, Moseley S, Fujita KP, Liese J, Rockman-Greenberg C, ENB-010-10 Study Group.
    J Clin Endocrinol Metab; 2019 Jul 01; 104(7):2735-2747. PubMed ID: 30811537
    [Abstract] [Full Text] [Related]

  • 17. Enzyme-replacement therapy in perinatal hypophosphatasia: Case report and review of the literature.
    Rougier H, Desrumaux A, Bouchon N, Wroblewski I, Pin I, Nugues F, Mornet E, Baujat G.
    Arch Pediatr; 2018 Oct 01; 25(7):442-447. PubMed ID: 30249491
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.